Bausch Health’s separation from its cash-rich eye care unit is officially underway, as the spinoff closes its public offering and the company taps a team to guide it into a “new chapter.” Too bad investors aren’t on the same page.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,